Prevacid by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.
Allergy alert: Do not use if you are allergic to lansoprazole
colloidal silicon dioxide, D&C red No. 28, FD&C blue No. 1, FD&C green No. 3, FD&C red No. 40, gelatin, hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, magnesium carbonate, methacryclic acid and ethyl acrylate copolymer, polyethylene glycol, polysorbate 80, starch, sucrose, sugar sphere, talc, titanium dioxide
NDC: 0067-6286-42
Treats Frequent Heartburn
PREVACID 24HR
Lansoprazole delayed-release capsules 15 mg / acid reducer
42 CAPSULES
THREE 14-DAY COURSES OF TREATMENT
Distributed by: GSK Consumer Healthcare, Warren, NJ 07059
Trademarks are owned by or licensed to the GSK group of companies.
©2019 GSK group of companies or its licensor.
KEEP THE CARTON AND PACKAGE INSERT. THEY CONTAIN IMPORTANT INFORMATION.
TAMPER-EVIDENT BOTTLE. DO NOT USE IF INNER FOIL SEAL IMPRINTED WITH “SEALED for YOUR PROTECTION” OR BLACK BAND AROUND THE CENTER OF EACH CAPSULE IS MISSING OR BROKEN.
62000000031308
| PREVACID
24 HR
lansoprazole capsule, delayed release |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263) |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PREVACID 74091884 1685731 Live/Registered |
TAKEDA PHARMACEUTICALS U.S.A., INC. 1990-08-23 |